TB-500 is an artificial peptide that undergoes laboratory analysis in respect of inter-cellular communication, molecular signaling, cytoskeleton physiology, and tissue-based biological pathways. The research on TB-500 is based on its connection to thymosin beta-4 (Tβ4) which is a natural peptide responsible for basic cellular functions.
TB-500
$99.99
Size / Strength
Every batch of TB-500 is independently third-party tested. 30-day money-back guarantee — no questions asked.
TB-500 – Research Overview
The research of TB-500 peptide was established with studies dedicated to the structure of the peptide, actin-dependent pathways, and other biological molecular interactions related to cell migrations. As an experimental substance, TB-500 continues to attract attention of scientists studying peptide-induced molecular signaling.
TB-500 10mg at Peptides Australia is available only in the form of the research-only laboratory reagent intended for experimental studies. Every batch of the product comes with the documents that cover analytical data and the corresponding Certificate of Analysis (COA).
Research Highlights
- Independent Laboratory Tested
- Batch-Specific Certificate of Analysis
- Australia-Wide Dispatch
- Research Use Only
- HPLC Tested Peptide Material
What is TB-500?
TB-500 is an artificial research peptide drug that is modelled from the peptide sequence isolated from thymosin beta-4 (Tβ4), a natural peptide existing in many biological systems.
Thymosin beta-4 is a small peptide playing a key role in various cellular activities, especially those related to actin control and intracellular organisation. Thymosin-like peptides are used by researchers in studying their function in molecular biology and cell signaling.
TB-500 was synthesised as a peptide analogue for scientific research. The design of TB-500 makes possible the study of particular peptide interaction and biological processes.
Research using TB-500 covers the following areas:
- Cellular signalling pathways
- Actin-binding mechanisms
- Molecular interactions
- Cytoskeletal biology
- Peptide chemistry
- Experimental biological models
The need for TB-500 is explained by the significance of studies on thymosin beta-4 in the area of cell biology. Researchers study the way of interaction of peptide molecules with cellular elements in order to obtain additional information about the biological processes.
In laboratory conditions, TB-500 is used as the object of experimental research, and not as a medicinal product.
It is necessary to emphasize the difference between research peptides and pharmaceuticals. TB-500 produced by research peptide manufacturers is considered as a Research Use Only (RUO) substance that is not approved in Australia for therapeutic, diagnostic, veterinary or human purposes.
Molecular Characteristics of TB-500
TB-500 is one of the synthetic peptide substances obtained in the process of peptide synthesis.
Stability Considerations
Several environmental variables affect peptide stability.
Among these, one will find:
- Temperature conditions
- Moisture conditions
- Protection from light
- Packaging conditions
- Conditions for transport
It is important for researchers to provide proper documentation during storage of peptides in laboratory practice.
Researchers may learn more about peptide science using the following educational resources:
- Understanding Peptide Purity
- Peptide Storage Conditions
- How to Interpret a Certificate of Analysis
Why Scientists Study TB-500
TB-500 is being researched because of its connection with thymosin beta-4 scientific studies and the basic biology of cells.
Science seeks to comprehend molecular mechanisms, and not to develop treatment methods.
Actin Biology Research
The main area of interest related to the thymosin-related peptides is actin biology.
Actin is a vital protein participating in:
- Organisation of the cell
- Structure of cytoskeleton
- Intracellular transportation
- Formation of cell shape
Cellular Signalling Research
Cells have communication pathways that involve complicated networks of molecular signaling.
Research into TB-500 focuses on potential interaction between these peptides and cellular signaling mechanisms.
Laboratory research into such issues can focus on:
- Mechanisms of signal communication
- Molecular interactions
- Cellular response
- Peptide-based interactions
Such research contributes to general knowledge about cellular biology.
Cytoskeletal Research
Cytoskeleton represents an essential element of the structure of a cell, which is involved in many cellular processes.
Thymosin-related peptides can be studied by researchers in relation to:
- Cytoskeletal organization
- Protein interactions
- Cellular architecture
- Molecular regulation
The research into the mechanisms of the cytoskeleton is an important field in cell biology research.
Applications in Molecular Biology
TB-500 offers researchers an experimental tool for studying peptide interactions and behavior.
Research applications can include:
- Laboratory research
- Investigations of molecular pathways
- Protein interactions research
- Cellular research models
Such research allows scientists to better understand peptide biology.
Experimental Research Models
Researchers can use laboratory models designed specifically to conduct experiments related to particular biological mechanisms.
Such approaches include:
- Biochemical analysis
- Cell-based experiments
- Molecular tests
- Analytic assessment
Such experiments have the goal of understanding biological processes.
Manufacturing & Quality Standards
High-quality research peptides require controlled manufacturing processes, analytical verification, and reliable documentation.
TB-500 10mg is produced using established peptide manufacturing techniques designed to support consistency and analytical evaluation
Solid Phase Peptide Synthesis (SPPS)
Manufacturing of synthetic peptides is often achieved using Solid Phase Peptide Synthesis (SPPS).
SPPS provides for assembly of amino acid units into an ordered sequence resulting in a certain peptide structure.
The general process of manufacturing involves:
- Peptide sequence preparation
- Solid phase synthesis
- Chemical work-up
- Purification
- Analysis
- Lyophilisation
- Batch record keeping
Manufacturing & Quality Standards (Continued)
After peptide synthesis, further quality control processes are necessary to ensure adequate characterisation and documentation of laboratory research materials.
For the purpose of TB-500 research peptides, quality control includes several steps to assess identity, purity, and batch uniformity of peptides.
Purification process
After the peptide synthesis, the purification process of the material is performed to remove extraneous products formed in the course of manufacture.
The purification process is essential because of the fact that synthetic peptide production might result in formation of related substances or incomplete peptides which need to be separated.
Quality-driven purification process improves:
- Analytical purity
- Batch uniformity
- Molecular characterisation
- Reliability of the research
Afterwards, the purified material is subjected to analysis and prepared for laboratory use.
Lyophilisation Process
The next step after purification and quality control is typically the conversion of TB-500 to a lyophilised powder form.
Freeze-drying is a technique for the removal of moisture under controlled conditions.
It ensures:
- Peptide stability
- Minimal contact with moisture
- Convenient storage in laboratories
- Controlled handling of the product
The final lyophilized product is packed together with identification and documentation of quality.
Traceability by Batch
Traceability is a key aspect of proper delivery of peptides.
Each batch of manufacture requires identifiable documentation that will enable scientists to assess relevant information.
Such batch documentation can contain:
- Product identification
- Batch identification
- Analytical data
- Manufacturing information
- Quality assessment documentation
Maintaining traceability enables research organizations to keep proper laboratory documentation.
Research Use Only (RUO)
TB-500 10mg sold by Peptides Australia is strictly available as a Research Use Only (RUO) laboratory product.
RUO status implies that this product can only be used for:
- Scientific research
- Laboratory investigation
- Analytical testing
- Educational purposes
TB-500 is not licensed in Australia for use as a therapeutic, diagnostic, veterinary or human product.
RUO Products Overview
Peptides for research are different from approved medicines.
Regulatory process includes:
- Assessment of safety information
- Manufacturing
- Quality considerations
- Approved applications
Peptides for research are provided as laboratory products intended for scientific study.
Responsible Research Practices
Scientists and organisations working with RUO products have to ensure compliance with:
- Institutional policies
- Laboratory safety
- Requirements for research
- Australian regulations
TB-500 is supposed to be used only in proper laboratory settings.
Why Choose Peptides Australia?
Choosing laboratory peptides demands trust in product information, testing, and supplier practices. Peptides Australia supplies research materials accompanied by quality information to help:
- Laboratory researchers
- Universities
- Biotechnology firms
- Scientific organizations
Batch-Specific Certificate of Analysis
The COA helps researchers obtain information associated with production batches.
It assists in:
- Product verification
- Laboratory documentation
- Research traceability
Independent Laboratory Testing
Testing helps in evaluation of:
- Peptide identity
- Purity properties
- Consistency of batch
HPLC Tested Peptides
Testing helps obtain analytical information about peptide composition and purity. Researchers can use this information while analyzing laboratory products for scientific investigations.
Proper Packaging
Packaging helps protect lyophilized peptide products during storage and Australia-wide delivery.
Australia-Wide Delivery
Delivery helps in provision of:
- Research laboratories
- Universities
- Biotechnology organizations
- Scientific researchers
Scientists planning to buy TB-500 in Australia must review Certificate of Analysis information, analytical testing, and quality practices of suppliers before choosing laboratory peptides.
This product is intended solely for laboratory research purposes. Not for human consumption.
TB-500 – Storage & Handling
Storage and Handling Instructions in Laboratories
Proper storage instructions play an essential role in the preservation of peptide quality and proper laboratory research. TB-500 is provided as a lyophilized powder and needs to be stored according to laboratory protocols.
Temperature
Researchers need to think about possible storage options where temperatures would not undergo frequent changes.
The following factors need to be considered:
- Maintenance of proper storage conditions
- Prevention of temperature changes
- Proper handling during delivery
Protection from Moisture
Proper protection of lyophilized peptide materials from moisture is necessary.
Some proper laboratory practices may include:
- Sealing of packaging
- Minimizing contact with humid environment
- Following storage instructions of suppliers
- Protection from Light
Proper protection of peptide materials from exposure to direct light is required.
Laboratory Documentation
Responsible research environments will usually keep records regarding:
- Batch information
- Storage conditions
- Product documentation
- Research procedures
Keeping records is part of laboratory quality management systems. Researchers can also refer to Peptide Storage Guidelines for more educational material.
TB-500 – Technical Specifications
Every batch of TB-500 is independently analysed before dispatch. The values below describe the current research batch.
| Product Name | TB-500 |
|---|---|
| CAS Number | 77591-33-4 | 885340-08-9 (fragment) |
| Molecular Formula | C₂₁₂H₃₅₀N₅₆O₇₈S |
| Molecular Weight | 889 g/mol |
| Quantity / Strength | 10mg |
| Purity | ≥ 99% (HPLC) |
| Form | Lyophilised Powder |
| Appearance | White Lyophilised Powder |
| Batch Number | PA-0060 |
| Storage Conditions | 2°C-8°C (Refrigerated) |
| Category | Healing & Recovery |
| Intended Use | Research Use Only — not for human consumption |
TB-500 – Certificate of Analysis
Every batch of TB-500 is independently tested before dispatch. View the full COA for the current batch below.
Certificate of Analysis (COA)
Batch Number PA-0060
| COA Information | Purpose |
|---|---|
| Product Name | Confirms product identification |
| Batch Number | Provides traceability |
| Purity Analysis | Reports analytical purity results |
| Testing Method | Identifies laboratory techniques used |
| Identity Testing | Supports compound confirmation |
| Quality Review | Documents batch assessment |
Purity Testing & Certificate of Analysis (COA)
Analytical verification is important when assessing research peptides. Scientists usually examine available analytical documentation prior to choosing laboratory materials.
High-Performance Liquid Chromatography (HPLC)
High-Performance Liquid Chromatography (HPLC) is among the most common procedures for assessing the purity of peptides.
In HPLC, separation of substances in the sample is carried out according to their chemical properties, and thus the obtained chromatogram enables an assessment of the share of the required peptide against the detected components.
HPLC testing can give details such as:
- Purity %
- Primary peptide peak
- Related substances
- Impurities profile
- Uniformity of batch
The results of HPLC analysis allow research laboratories to assess the analytical properties of peptide substances.
LC-MS Identity Verification
Liquid Chromatography–Mass Spectrometry (LC-MS) is often conducted together with HPLC for peptide identity verification.
In LC-MS analysis, information about molecular mass is provided, which assists researchers to confirm the presence of the expected substance.
This method can be helpful to:
- Confirm molecular weight
- Verify identity
- Conduct structural analysis
Combination of different analytical methods leads to a more thorough quality assessment of peptides.
Scientists interested in laboratory testing methods should pay attention to:
- Understanding Peptide Purity
- HPLC vs LC-MS Testing
- Third-Party Laboratory Testing
Certificate of Analysis Explained
A Certificate of Analysis (COA) is a batch-specific quality document containing analytical information about a research peptide.
A typical COA may include:
Reviewing the Certificate of Analysis (COA) aids scientists in getting to know the properties of laboratory samples before conducting research.
Proper documentation is critical for good laboratory practice in universities, biotechnology companies, and scientific organizations.
Research Disclaimer
This content is provided for educational, scientific and research-information purposes only. It does not provide medical advice, treatment recommendations or personal dosage instructions. Available evidence relevant to TB-500 and related thymosin beta-4 research includes preclinical studies and limited clinical investigation of related compounds or mechanisms. Further research is required to establish the safety, pharmacology and potential efficacy of TB-500 for specific research applications.
- Not for human or veterinary use
- No claims are made regarding safety or efficacy in humans
- Must be handled with appropriate laboratory safety equipment
- Purchaser assumes all responsibility for legal, compliant use
References
5 sources- 1Malinda KM, Sidhu GS, Mani H, et al. Thymosin Beta4 Accelerates Wound Healing. Journal of Investigative Dermatology. 1999;113(3):364-368.PubMed: https://pubmed.ncbi.nlm.nih.gov/10469335/
- 2Philp D, Nguyen M, Scheremeta B, et al. Thymosin Beta4 Promotes Angiogenesis, Wound Healing, and Hair Follicle Development. Mechanisms of Ageing and Development. 2004;125(2):113-115.PubMed: https://pubmed.ncbi.nlm.nih.gov/15037013/
- 3Goldstein AL, Hannappel E, Kleinman HK. Thymosin Beta4: A Multi-Functional Regenerative Peptide. Basic Properties and Clinical Applications. Expert Opinion on Biological Therapy. 2012;12(1):37-51.PubMed: https://pubmed.ncbi.nlm.nih.gov/22074294/
- 4Sosne G, Qiu P, Goldstein AL, Wheater M. Biological Activities of Thymosin Beta4 Defined by Active Sites in Short Peptide Sequences. FASEB Journal. 2010;24(7):2144-2151.PubMed: https://pubmed.ncbi.nlm.nih.gov/20179146/
- 5Australian Government, Therapeutic Goods Administration (TGA). Concerns Regarding the Public Health Risks Associated with Unapproved Peptide Products. Therapeutic Goods Administration. 2026.TGA: https://www.tga.gov.au/news/media-releases/concerns-regarding-public-health-risks-associated-unapproved-peptide-products
Citations are provided for research reference and open in a new tab. Listing a study does not imply it evaluated this specific product.
TB-500 – Frequently Asked Questions
Why Researchers Choose Us






